This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other surgical follow-up care
Z21_OTHER_SURGI_FOLLOW__CARE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1286 |
4. Check minimum number of eventsNone |
1286 |
5. Include endpointsNone |
1286 |
6. Filter based on genotype QC (FinnGen only) |
1286 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_SPECIFIC_PROCED_HEALTH_CARE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z4|Z5[0-4]
Similar endpoints
↥List of similar endpoints to
Other surgical follow-up care
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for specific procedures and health care
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1286 | 782 | 504 |
| Unadjusted period prevalence (%) | 0.25 | 0.27 | 0.22 |
| Median age at first event (years) | 50.93 | 46.31 | 58.10 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1130
- Matched controls
- 11301
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z48.8
ICD-10 Finland
Other specified surgical follow-up care
881.4
323.0
564
13
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
55.0
323.0
429
124
Z48.9
ICD-10 Finland
Surgical follow-up care, unspecified
723.6
190.8
183
*
TQW40
NOMESCO Finland
Remowal of suture of skin
7.7
79.2
198
304
Z3231
NOMESCO Finland
Registered nurse
3.4
67.6
423
1682
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
40.3
62.9
79
21
R4110
NOMESCO Finland
Physiotherapy
3.3
58.4
377
1502
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
38.5
49.0
62
17
Z50.1
ICD-10 Finland
Other physical therapy
19.3
41.9
64
35
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
+∞
39.8
38
*
Z71.8
ICD-10 Finland
Other specified counselling
2.6
38.2
347
1639
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.3
35.6
140
356
ZXD05
NOMESCO Finland
Urgent procedure
2.4
34.4
402
2146
N02BE01
ATC
paracetamol; systemic, rectal
2.7
34.3
969
7822
ZXA00
NOMESCO Finland
Right side
2.5
34.2
327
1571
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
20.1
33.3
50
26
B01AB05
ATC
enoxaparin; parenteral
2.4
32.7
350
1777
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
3.5
32.0
162
513
ZXA05
NOMESCO Finland
Left side
2.5
31.1
298
1424
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
30.3
30.9
41
14
Z3226
NOMESCO Finland
Physiotherapist
2.7
29.7
239
1031
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.3
29.4
162
544
Z2221
NOMESCO Finland
Medical doctor
2.2
28.5
352
1892
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
2.9
27.8
187
721
J01DB01
ATC
cefalexin; oral
2.3
27.3
926
7534
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
+∞
27.2
26
*
ZX120
NOMESCO Finland
Intravenous
3.5
27.2
135
419
N02AX02
ATC
tramadol; systemic, rectal
2.0
25.7
447
2759
N02AA05
ATC
oxycodone; systemic
3.1
25.2
148
519
WX320
NOMESCO Finland
Spinalanesthesy
2.3
25.1
270
1345
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
24.4
236
1115
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
24.2
387
2296
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
24.0
233
1101
Z51.5
ICD-10 Finland
Palliative care
15.7
21.6
35
23
Z20.9
ICD-10 Finland
Contact with and exposure to unspecified communicable disease
5.2
21.1
67
136
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
3.7
20.6
95
277
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
20.0
104
334
ZXE00
NOMESCO Finland
One hour or less
1.8
19.8
449
2976
N03AX16
ATC
pregabalin; oral
2.2
19.6
242
1268
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.5
19.3
70
164
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.5
18.9
91
275
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.9
18.8
124
466
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
18.6
378
2401
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
18.5
180
844
M79.6
ICD-10 Finland
Pain in limb
1.8
18.2
392
2533
V18
ICD-10 Finland
Pedal cyclist injured in noncollision transport accident
14.6
18.2
30
21
O60
ICD-10 Finland
Preterm labour and delivery
5.5
18.0
54
103
Z25.1
ICD-10 Finland
Need for immunization against influenza
3.6
18.0
83
242
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
18.0
400
2612
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
17.9
307
1831
P01AB01
ATC
metronidazole; oral, rectal
1.8
17.6
424
2838
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
5.0
17.4
56
116
Z3229
NOMESCO Finland
Other healthcare associate professional
3.1
17.1
97
330
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
17.0
400
2649
C03CA01
ATC
furosemide; systemic
2.0
16.8
251
1415
J01FF01
ATC
clindamycin; systemic
1.9
16.7
300
1809
R50.9
ICD-10 Finland
Fever, unspecified
2.3
16.2
168
811
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
16.1
471
3322
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
16.1
121
494
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.8
16.1
70
195
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
16.0
222
1212
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
16.0
291
1763
RD211
NOMESCO Finland
NA
3.9
15.9
66
177
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
15.8
282
1692
A02BC02
ATC
pantoprazole; systemic
1.7
15.6
634
4898
O82.0
ICD-10 Finland
Delivery by elective caesarean section
3.7
15.4
69
197
R4120
NOMESCO Finland
Occupational therapy
3.2
15.3
83
275
J01MA02
ATC
ciprofloxacin; systemic
1.7
14.8
395
2691
J34.2
ICD-10 Finland
Deviated nasal septum
3.4
14.7
71
216
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
14.7
166
829
Z49.1
ICD-10 Finland
Extracorporeal dialysis
+∞
14.6
14
*
DJD20
NOMESCO Finland
Plastic repair of septum of nose
4.2
14.5
55
136
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
2.9
14.4
88
316
R52.9
ICD-10 Finland
Pain, unspecified
2.6
14.4
107
434
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
8.8
14.3
30
35
Z00.0
ICD-10 Finland
General medical examination
2.0
14.3
213
1192
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
14.2
183
966
WX402
NOMESCO Finland
General anaesthesia
2.1
14.2
181
953
W17
ICD-10 Finland
Other fall from one level to another
3.4
14.0
68
208
W92
ICPC
Compl labour/ delivery livebirth
4.4
14.0
50
117
X58
ICD-10 Finland
Exposure to other specified factors
2.2
13.9
161
810
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
9.8
13.7
27
28
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
13.7
387
2671
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
13.6
196
1080
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
13.5
116
506
M25.5
ICD-10 Finland
Pain in joint
1.8
13.3
290
1849
ZXD35
NOMESCO Finland
Usual procedure
4.1
13.1
51
130
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
12.9
156
802
A28
ICPC
Limited function/disability NOS
2.2
12.8
136
659
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.9
12.7
78
282
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
3.0
12.7
73
253
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
12.6
137
669
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
5.6
12.6
36
66
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
4.1
12.6
48
120
H25.9
ICD-10 Finland
Senile cataract, unspecified
6.7
12.5
31
47
Z47.8
ICD-10 Finland
Other specified orthopaedic follow-up care
+∞
12.5
12
*
Z71.9
ICD-10 Finland
Counselling, unspecified
2.9
12.5
78
285
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
12.5
762
6359
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
12.5
196
1116
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
13.3
12.5
21
16
R51.80
ICD-10 Finland
Headache
2.0
12.3
173
942
XF404
NOMESCO Finland
Ambulatory ECG
2.5
12.2
102
439
N03AX12
ATC
gabapentin; oral
2.1
12.2
147
755
FM1QE
NOMESCO Finland
Extensive ultrasound of fetal heart
8.8
12.0
25
29
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
3.4
11.7
56
170
B01AB10
ATC
tinzaparin; parenteral
2.9
11.5
70
250
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
4.7
11.3
37
80
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
11.2
190
1108
WX002
NOMESCO Finland
Sedation and analgesia
1.9
11.0
186
1084
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
10.9
207
1255
ZZA00
NOMESCO Finland
Split skin graft
4.4
10.9
38
88
S15
ICPC
Foreign body in skin
2.7
10.7
71
269
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
28.3
10.7
14
5
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.3
10.7
39
94
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
10.7
366
2616
A02BC05
ATC
esomeprazole; systemic
1.6
10.7
377
2719
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
10.7
95
423
M01AE02
ATC
naproxen; oral, rectal
1.5
10.7
598
4801
N30.0
ICD-10 Finland
Acute cystitis
1.9
10.6
153
841
XF402
NOMESCO Finland
ECG with work load test
2.2
10.6
112
541
UJF32
NOMESCO Finland
Coloscopy
1.7
10.6
235
1495
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.1
10.6
127
650
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.9
10.5
165
934
WZC30
NOMESCO Finland
Teaching
2.0
10.5
131
680
M54.5
ICD-10 Finland
Low back pain
1.6
10.5
325
2265
R4130
NOMESCO Finland
Speech therapy
6.0
10.5
28
48
Z01.7
ICD-10 Finland
Laboratory examination
2.1
10.5
124
630
TNX99
NOMESCO Finland
Other orthopaedic minor procedure
3.9
10.4
41
107
M03BC01
ATC
orphenadrine (citrate); systemic
1.7
10.3
234
1493
R39.1
ICD-10 Finland
Other difficulties with micturition
4.1
10.3
39
98
R5110
SPAT
NA
4.8
10.2
33
71
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
10.2
233
1494
J01FA06
ATC
roxithromycin; oral
1.6
10.2
394
2898
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.2
10.1
37
90
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.5
10.1
81
344
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
10.1
104
499
Z29.8
ICD-10 Finland
Other specified prophylactic measures
3.7
9.9
42
117
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
9.7
300
2081
EB1AA
SPAT
NA
2.9
9.5
59
214
R4190
NOMESCO Finland
Nutritional therapy
3.3
9.4
46
144
WX290
SPAT
NA
3.5
9.4
43
128
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.3
9.4
85
385
MA3AE
NOMESCO Finland
Combined first trimester screening
2.5
9.3
70
287
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
9.3
169
1007
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.6
9.2
67
270
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
9.2
181
1101
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
2.1
9.2
103
512
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
2.0
9.2
113
581
X50
ICD-10 Finland
Overexertion and strenuous or repetitive movements
4.1
9.2
34
84
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.1
9.2
98
478
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.8
9.1
57
208
J01MA12
ATC
levofloxacin; systemic
1.8
9.1
164
973
A10AE04
ATC
insulin glargine; parenteral
2.2
9.1
91
431
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.4
9.1
77
335
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
9.1
486
3814
FM1NE
NOMESCO Finland
Ultrasound examination of fetal heart
15.7
9.0
14
9
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.3
9.0
32
76
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
9.0
424
3236
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
9.0
223
1456
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
9.0
205
1306
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
9.0
60
229
C07AB07
ATC
bisoprolol; oral
1.5
8.9
395
2973
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
8.8
106
542
W84
ICPC
Pregnancy high risk
2.8
8.8
55
202
N05CF01
ATC
zopiclone; oral
1.6
8.8
289
2031
Z97.4
ICD-10 Finland
Presence of external hearing-aid
4.8
8.8
28
60
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.8
8.7
164
986
H02AB06
ATC
prednisolone; systemic
1.5
8.6
436
3367
M01AH05
ATC
etoricoxib; oral
1.5
8.5
550
4464
WX892
NOMESCO Finland
Monitored bed care
2.4
8.5
73
320
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.7
8.5
58
226
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
20.2
8.5
12
6
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.8
8.5
53
194
M02AA07
ATC
piroxicam; topical
1.5
8.4
323
2349
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
8.4
36
102
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.8
8.4
20
30
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.9
8.4
18
23
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
8.3
230
1544
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
8.3
57
222
A04AA01
ATC
ondansetron; systemic, rectal
2.5
8.3
63
259
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
8.3
67
287
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
4.5
8.3
28
64
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.4
8.2
70
308
Z13.5
ICD-10 Finland
Special screening examination for eye and ear disorders
7.6
8.2
18
24
V28.9
ICD-10 Finland
Motorcycle rider injured in noncollision transport accident, unspecified motorcycle rider injured in traffic accident
11.8
8.1
14
12
RJ411
NOMESCO Finland
NA
17.3
8.1
12
7
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
8.0
544
4438
R1250
NOMESCO Finland
Evaluation of functional capability
4.6
8.0
26
57
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
2.0
8.0
106
562
N06AX21
ATC
duloxetine; oral
2.0
8.0
100
520
Z2446
NOMESCO Finland
Social worker
2.3
8.0
71
320
A02BC01
ATC
omeprazole; systemic
1.6
7.9
260
1821
M48.0
ICD-10 Finland
Spinal stenosis
2.0
7.9
98
510
M03BX02
ATC
tizanidine; oral
1.4
7.9
596
4953
TNH33
NOMESCO Finland
Custom moulded brace, ankle or foot
5.2
7.9
23
45
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
7.8
242
1674
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
7.8
64
278
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
7.7
106
570
R13
ICD-10 Finland
Dysphagia
2.5
7.7
60
251
J45.8
ICD-10 Finland
Mixed asthma
3.5
7.7
34
99
Z11.2
ICD-10 Finland
Special screening examination for other bacterial diseases
15.1
7.7
12
8
TNX34
NOMESCO Finland
Major custom molded cast, unspecified region
5.6
7.7
21
38
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.6
7.7
56
226
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
2.6
7.6
53
209
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
18.5
7.6
11
6
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.1
7.6
28
70
Z29.0
ICD-10 Finland
Isolation
25.2
7.6
10
*
TK800
NOMESCO Finland
Hemodialysis
5.8
7.5
20
35
L28
ICPC
Limited function/disability (L)
1.8
7.5
126
730
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.0
7.5
41
141
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.6
7.5
53
213
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
7.4
269
1921
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
7.4
109
603
ZXA10
NOMESCO Finland
Bilateral
1.7
7.4
169
1076
ZY010
NOMESCO Finland
Hospital outpatient
2.4
7.4
61
265
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
7.4
175
1126
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
4.4
7.4
25
58
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
7.3
465
3725
Z13.6
ICD-10 Finland
Special screening examination for cardiovascular disorders
10.9
7.3
13
12
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
+∞
7.3
7
*
Z51.4
ICD-10 Finland
Preparatory care for subsequent treatment, not elsewhere classified
+∞
7.3
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.3
7
*
Z49.0
ICD-10 Finland
Preparatory care for dialysis
+∞
7.3
7
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.5
7.3
24
54
N05AH04
ATC
quetiapine; oral
1.7
7.2
166
1056
R42
ICD-10 Finland
Dizziness and giddiness
1.6
7.2
190
1256
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
15.9
7.2
11
7
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.6
7.2
31
89
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
7.2
62
273
Z50.5
ICD-10 Finland
Speech therapy
7.4
7.2
16
22
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
7.2
118
678
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
30.2
7.2
9
*
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
7.1
485
3930
M01AH01
ATC
celecoxib; oral (coxibs)
1.7
7.1
151
941
R06.0
ICD-10 Finland
Dyspnoea
1.6
7.1
206
1397
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
7.1
143
879
SXC03
NOMESCO Finland
Other oral or dental procedure
6.1
7.1
18
30
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
7.1
141
863
M54.8
ICD-10 Finland
Other dorsalgia
2.8
7.1
42
152
B01AA03
ATC
warfarin; systemic
1.7
7.1
158
998
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
2.2
7.0
67
312
I20.90
ICD-10 Finland
Angina pectoris, unspecified
3.3
7.0
33
102
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
7.0
82
415
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.2
7.0
34
108
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
1.7
6.9
149
930
S18
ICPC
Laceration/cut
1.4
6.9
374
2901
M79.1
ICD-10 Finland
Myalgia
1.8
6.9
121
711
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
13.9
6.9
11
8
N18.0
ICD-10 Finland
End-stage renal disease
13.9
6.9
11
8
QWC00
NOMESCO Finland
Reoperation for superficial infection in surgery of skin
13.9
6.9
11
8
WX110
NOMESCO Finland
Local anesthesy
1.4
6.9
710
6178
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.2
6.9
68
322
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.1
6.9
71
344
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
6.9
71
344
C07AB02
ATC
metoprolol; systemic
1.6
6.9
167
1079
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
6.9
195
1315
A06AD11
ATC
lactulose; oral
1.8
6.9
121
714
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
2.0
6.9
86
451
S97
ICPC
Chronic ulcer skin
2.6
6.8
48
191
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.8
582
4891
J01DA01
ATC
[U] cefalexin; systemic
1.4
6.8
622
5289
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
4.6
6.8
22
49
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
6.1
6.8
17
28
Z51.6
ICD-10 Finland
Desensitization to allergens
40.3
6.8
8
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
6.8
508
4177
RJ190
NOMESCO Finland
NA
16.8
6.7
10
6
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.1
6.7
24
59
R60.0
ICD-10 Finland
Localized oedema
1.9
6.6
94
515
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.7
6.6
125
752
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
6.6
229
1617
QCB00
NOMESCO Finland
Suture of skin of upper limb
4.2
6.5
23
56
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
6.5
945
8716
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
6.5
72
358
AN1
HP
Coronary angiography
1.9
6.5
89
483
N05BA04
ATC
oxazepam; oral
1.5
6.5
232
1651
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
5.4
6.5
18
34
J01AA02
ATC
doxycycline; systemic
1.4
6.4
751
6632
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.8
6.4
103
589
RJ421
NOMESCO Finland
NA
14.4
6.4
10
7
R2110
NOMESCO Finland
Giving the first information
2.1
6.4
67
326
WX203
NOMESCO Finland
Infraclavicular plexus blockade
3.4
6.4
29
88
AA1AD
NOMESCO Finland
CT of head and brain
1.6
6.4
191
1303
A11CC03
ATC
alfacalcidol; systemic
4.9
6.4
19
39
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.8
6.4
99
560
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
6.4
249
1806
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.9
6.4
97
545
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
6.4
97
545
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
6.6
6.3
15
23
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.2
6.3
30
94
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.7
6.3
134
833
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
1.5
6.3
214
1501
W10
ICD-10 Finland
Fall on and from stairs and steps
2.4
6.3
51
219
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.3
6.3
57
260
A46
ICD-10 Finland
Erysipelas
1.8
6.3
113
671
Z54.0
ICD-10 Finland
Convalescence following surgery
6.0
6.3
16
27
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
5.5
6.3
17
31
RJ410
NOMESCO Finland
NA
11.1
6.3
11
10
IHA10
SPAT
NA
9.3
6.3
12
13
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.8
6.3
102
587
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
2.8
6.3
37
134
TQW99
NOMESCO Finland
Other minor procedure on skin
2.4
6.3
48
202
Z49.2
ICD-10 Finland
Other dialysis
+∞
6.3
6
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
3.2
6.3
30
95
RF410
NOMESCO Finland
NA
4.8
6.2
19
40
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.3
6.2
54
242
R07.0
ICD-10 Finland
Pain in throat
2.0
6.2
73
374
R11
ICD-10 Finland
Nausea and vomiting
2.0
6.2
77
403
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.3
6.2
51
223
J01EA01
ATC
trimethoprim; systemic
1.5
6.2
239
1725
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.4
6.2
48
204
A12AA04
ATC
calcium carbonate; oral
6.3
6.2
15
24
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.4
6.2
17
32
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.0
6.2
80
424
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
6.1
724
6375
S82.2
ICD-10 Finland
Fracture of shaft of tibia
4.3
6.1
21
50
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.0
6.1
78
412
N18.8
ICD-10 Finland
Other chronic renal failure
4.1
6.1
22
55
M01AB05
ATC
diclofenac; systemic, rectal
1.4
6.1
627
5394
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.8
6.1
37
137
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.0
6.1
33
114
Z39.2
ICD-10 Finland
Routine postpartum follow-up
1.6
6.1
143
918
C07AA05
ATC
propranolol; systemic
1.5
6.1
188
1293
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.4
6.1
47
199
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
6.1
162
1073
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
6.1
89
493
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.6
6.1
175
1183
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
6.7
6.0
14
21
A06AH03
ATC
naloxegol; oral
10.1
6.0
11
11
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.5
6.0
26
76
N06AX11
ATC
mirtazapine; oral
1.4
6.0
283
2127
J01CF05
ATC
flucloxacillin; systemic
2.6
6.0
41
163
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
351
1406
3.06
63.47
4.0
2.5
e6/l
2.9
2.9
0.02
241
736
(3021589) Normoblasts [#/volume] in Blood
736
4408
2.57
58.90
12.1
8.2
e9/l
0.0
0.0
1.32
614
3579
(3026782) Osmolality of Urine
379
1755
2.64
50.64
4.0
2.4
mosm/kgh2o
546.0
559.1
0.51
326
1489
(3002582) Erythrocytes [#/volume] in Urine
506
2737
2.40
47.93
4.6
2.8
e6/l
133.1
63.1
0.34
409
2041
(3018095) Leukocytes [#/volume] in Urine
584
3370
2.34
47.56
6.0
3.1
e6/l
127.6
94.6
0.47
430
2236
(3044640) Blood type and Crossmatch panel - Blood
528
3011
2.28
43.17
2.9
2.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
442
2421
2.26
39.01
6.8
5.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
412
2247
2.23
36.28
4.9
3.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
246
1075
2.59
35.71
2.2
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
440
2527
2.13
33.49
4.0
2.7
e6/l
0.5
0.4
0.25
351
1855
(3022217) INR in Platelet poor plasma by Coagulation assay
224
966
2.60
33.24
22.4
24.0
inr
1.7
1.3
—
6
122
(3042936) Bacteria identified in Isolate by Culture
256
1241
2.33
29.14
2.5
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
420
2497
2.01
28.17
3.9
2.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
675
4764
1.88
26.58
7.8
5.7
%
27.7
29.0
2.38
640
4432
(3018010) Neutrophils/100 leukocytes in Blood
669
4711
1.88
26.50
7.7
5.4
%
57.4
56.5
1.38
633
4396
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
387
2290
1.99
25.93
2.8
2.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
225
1081
2.31
25.93
3.1
2.0
%
21.7
23.7
1.43
212
920
(3022096) Basophils/100 leukocytes in Blood
634
4414
1.86
25.80
7.8
5.7
%
0.6
0.7
1.20
598
4098
(3026008) Bacteria identified in Urine by Culture
452
2825
1.93
25.75
3.5
2.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
285
1520
2.12
25.32
3.4
2.4
e6/l
1.2
1.0
0.26
175
842
(3021447) Carbon dioxide [Partial pressure] in Venous blood
171
734
2.53
25.27
3.9
3.5
kpa
5.9
5.9
0.10
165
709
(3014111) Lactate [Moles/volume] in Serum or Plasma
167
709
2.56
25.25
7.0
7.5
mmol/l
1.3
1.3
0.01
151
684
(3006504) Eosinophils/100 leukocytes in Blood
650
4582
1.85
25.22
7.7
5.6
%
2.8
2.9
0.13
608
4242
(3022948) Iron [Moles/volume] in Serum or Plasma
254
1304
2.18
24.84
2.9
1.9
umol/l
13.0
13.8
0.79
238
1186
(3019069) Monocytes/100 leukocytes in Blood
651
4614
1.83
24.60
7.8
5.9
%
8.5
8.4
0.50
614
4308
(3024354) Oxygen [Partial pressure] in Venous blood
151
619
2.63
24.50
3.0
3.4
kpa
4.7
4.5
0.59
145
599
(3002385) Erythrocyte distribution width [Ratio]
1059
8816
2.14
23.89
26.8
13.4
%
13.7
13.5
4.59
1050
8617
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
188
865
2.37
23.82
3.5
2.2
u/l
34.5
38.2
0.29
164
738
(3002032) Base excess in Venous blood by calculation
168
736
2.48
23.71
4.4
3.5
mmol/l
1.9
1.9
0.01
140
580
(3004789) Transferrin [Mass/volume] in Serum or Plasma
234
1183
2.20
23.69
3.0
1.9
g/l
2.4
2.4
0.35
224
1089
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
657
4708
1.81
23.58
7.0
5.2
umol/l
10.8
11.1
0.38
623
4423
(42870588) Differential panel, method unspecified - Blood
489
3213
1.84
23.30
7.7
5.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
162
704
2.49
23.25
5.7
4.4
%
0.1
0.1
0.31
45
181
(3013826) Glucose [Moles/volume] in Serum or Plasma
741
5532
1.80
22.91
5.8
4.2
mmol/l
6.6
6.6
0.28
693
5082
(3012095) Magnesium [Moles/volume] in Serum or Plasma
248
1304
2.12
22.63
4.0
2.9
mmol/l
0.8
0.8
0.04
238
1217
(3025159) Blasts/100 leukocytes in Blood
154
666
2.49
22.30
5.9
4.4
%
0.0
0.1
1.20
39
152
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
108
390
2.93
22.27
5.1
4.0
mmol/l
24.0
24.2
0.27
103
355
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
649
4685
1.78
22.26
4.4
3.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
165
738
2.42
22.20
5.7
4.3
%
0.8
0.8
0.11
47
199
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
122
474
2.74
21.95
1.8
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
623
4462
1.77
21.80
8.6
5.3
mmol/l
1.2
1.2
0.62
560
3753
(3019198) Lymphocytes [#/volume] in Blood
687
5066
1.76
21.67
7.7
5.5
e9/l
1.8
2.0
1.97
603
4451
(3013115) Eosinophils [#/volume] in Blood
685
5087
1.74
20.71
7.8
5.8
e9/l
0.2
0.2
0.55
597
4449
(3021601) Nitrite [Presence] in Urine by Test strip
680
5059
1.73
20.25
6.0
4.4
estimate
0.0
0.0
0.50
165
945
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
85
283
3.15
20.18
2.1
2.9
g/l
3.6
3.5
0.08
80
277
(3006315) Basophils [#/volume] in Blood
664
4911
1.73
20.17
7.5
5.5
e9/l
0.0
0.0
1.87
570
4228
(3001604) Monocytes [#/volume] in Blood
662
4893
1.73
20.15
7.4
5.5
e9/l
0.6
0.6
0.85
569
4210
(3024561) Albumin [Mass/volume] in Serum or Plasma
548
3845
1.74
20.11
6.5
4.1
g/l
35.4
36.2
2.65
516
3562
(3000991) Gas panel - Venous blood
150
679
2.37
19.57
8.8
8.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
681
5108
1.71
19.34
4.4
3.3
estimate
0.0
0.0
0.80
162
901
(3013650) Neutrophils [#/volume] in Blood by Automated count
741
5689
1.71
19.29
11.0
7.8
e9/l
4.2
4.0
0.69
644
4925
(3020779) Urea [Moles/volume] in Serum or Plasma
144
647
2.38
19.10
9.9
5.4
mmol/l
9.0
8.6
0.25
139
610
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
904
7365
1.77
18.68
9.4
6.2
u/l
78.7
75.0
1.92
862
6864
(3035350) Ketones [Presence] in Urine by Test strip
669
5042
1.68
18.26
4.4
3.3
estimate
0.0
0.0
0.50
153
927
(3000850) Epithelial cells [#/volume] in Urine
310
1903
1.83
17.56
3.2
2.3
e6/l
8.2
6.4
0.86
248
1664
(3014576) Chloride [Moles/volume] in Serum or Plasma
194
1018
2.07
17.50
8.1
7.0
mmol/l
104.5
104.4
0.13
194
995
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
206
3.32
17.42
3.3
3.7
u/ml
0.3
0.4
2.13
34
120
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
560
4063
1.67
17.41
7.2
4.9
mmol/l
1.2
1.2
0.54
523
3675
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
516
3667
1.68
17.35
2.1
1.9
pmol/l
90.6
97.3
2.69
283
1867
(3032080) INR in Blood by Coagulation assay
490
3447
1.68
17.05
11.4
7.8
inr
1.2
1.2
0.30
179
1027
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
129
583
2.35
16.84
1.5
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1085
9449
1.95
16.76
19.7
9.9
ml/min/173m2
86.2
86.0
0.10
955
7557
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
189
1001
2.04
16.58
3.0
2.9
umol/l
7.8
7.0
0.26
170
849
(40768804) Tissue Pathology biopsy report
534
3871
1.65
16.36
2.3
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
216
1209
1.95
16.17
1.3
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
140
672
2.22
15.83
4.7
4.2
%
0.5
0.5
0.10
35
148
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
269
1639
1.81
15.39
4.7
3.3
ng/l
227.1
522.1
1.75
204
1182
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
114
509
2.36
15.28
1.6
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
542
3999
1.61
15.12
2.6
2.2
nmol/l
73.9
76.0
0.93
495
3615
(3044889) 12 lead EKG panel
817
6657
1.62
15.01
4.0
3.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
169
890
2.03
15.00
2.1
2.0
nmol/l
371.9
371.9
0.00
159
809
(3041096) Erythrocytes [Presence] in Urine by Automated
404
2785
1.66
14.73
4.3
2.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
850
7023
1.62
14.47
5.4
3.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
65
230
2.92
13.91
2.1
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
16
17
9.52
13.45
1.3
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
317
2096
1.68
13.37
1.6
1.5
nmol/l
19.7
21.1
1.09
284
1779
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1143
10317
1.97
13.22
21.6
11.0
mg/l
23.4
22.7
0.31
1005
7911
(3036489) Thrombin time
86
362
2.47
13.12
2.0
2.5
s
20.6
21.7
1.39
81
323
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
328
2198
1.66
13.11
1.8
1.8
mg/l
1.0
1.0
0.13
255
1634
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
433
3138
1.57
12.42
3.6
3.1
u/l
30.1
31.4
0.39
413
2978
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
19
28
6.87
12.32
3.3
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
442
3232
1.56
12.13
1.7
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
320
2178
1.62
11.87
1.5
1.4
g/l
2.5
2.3
1.10
192
1330
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
308
2094
1.62
11.42
2.0
1.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
182
1073
1.81
11.39
8.4
4.1
mmol/l
1.1
1.0
1.46
173
981
(3024263) Appearance of Synovial fluid
20
34
5.96
11.35
1.7
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
334
2324
1.59
11.22
2.9
2.4
umol/l
2832.1
6446.6
1.09
302
2039
(3023183) Ammonium ion [Moles/volume] in Plasma
48
166
2.96
10.74
1.8
3.3
umol/l
34.8
37.0
0.24
42
137
(3024928) Oxygen saturation in Venous blood
45
150
3.07
10.73
1.9
3.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
82
372
2.29
10.61
1.5
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
31
82
3.85
10.52
2.7
2.9
mg/l
201.4
17.8
0.55
20
60
(3052851) Hemolysis interference index of Serum or Plasma
61
243
2.59
10.47
3.2
3.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
12
12
10.08
10.45
1.4
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
162
952
1.80
10.21
1.9
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
595
4753
1.47
10.19
3.6
2.6
ug/l
99.5
99.4
0.01
560
4377
(3018418) pH of Serum or Plasma
364
2633
1.53
10.14
4.2
3.0
ph
7.4
7.4
0.27
63
477
(46235355) HIV 1 and 2 tests - Meaningful Use set
358
2584
1.53
10.06
2.3
2.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1124
10290
1.73
9.70
22.4
12.4
mmol/l
139.2
139.6
6.47
1112
9988
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
446
3392
1.48
9.68
3.9
3.2
ng/l
36.9
49.6
0.45
264
2116
(3013512) EKG study
356
2585
1.52
9.67
4.5
3.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
159
958
1.75
9.18
1.9
1.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
339
2460
1.51
9.17
2.7
2.1
mg/l
2.8
2.9
0.51
288
2057
(3019832) Treponema pallidum Ab [Presence] in Serum
242
1636
1.59
8.97
1.9
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
322
2322
1.52
8.94
3.0
2.7
ng/l
1983.6
1117.3
1.55
289
1932
(3023103) Potassium [Moles/volume] in Serum or Plasma
1123
10326
1.69
8.92
22.6
12.5
mmol/l
3.9
3.9
0.04
1106
10005
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
13
18
7.29
8.85
3.1
3.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
35
114
3.13
8.71
3.4
2.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
382
2869
1.47
8.64
4.0
2.3
u/l
53.5
57.4
1.78
363
2623
(3017143) Hepatitis C virus Ab [Presence] in Serum
201
1312
1.63
8.59
1.9
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
403
3064
1.46
8.54
3.7
2.8
mmol/l
2.4
2.4
0.23
349
2695
(3037522) Nuclear Ab [Titer] in Serum
204
1351
1.61
8.20
1.4
1.3
titre
375.4
542.8
1.06
39
263
(3013707) Erythrocyte sedimentation rate by Westergren method
845
7382
1.42
7.99
4.8
3.7
mm/h
11.8
10.6
1.62
799
6812
(3027945) Reticulocytes/100 erythrocytes in Blood
148
910
1.71
7.94
2.8
2.5
%
1.8
1.7
0.23
141
802
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
355
2670
1.46
7.85
2.3
2.0
u/l
183.3
258.1
0.95
337
2508
(1761482) Bacteria [#/volume] in Urine by Culture
49
203
2.47
7.82
3.5
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
493
3944
1.41
7.72
4.6
3.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
153
959
1.68
7.64
1.7
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
145
903
1.68
7.41
8.2
7.3
kpa
5.1
5.1
0.12
137
865
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
110
634
1.80
7.38
3.0
2.3
u/l
4951.2
4220.6
0.14
54
265
(3027801) Oxygen [Partial pressure] in Arterial blood
145
904
1.68
7.38
8.2
7.3
kpa
12.3
12.3
0.05
138
867
(3023520) Reticulocytes [#/volume] in Blood
113
659
1.78
7.29
2.3
2.7
e9/l
67.2
70.2
0.35
74
497
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
335
2528
1.44
7.18
1.4
1.3
u/ml
1.3
1.5
0.18
103
667
(3003396) Base excess in Arterial blood by calculation
144
905
1.67
7.11
8.2
7.4
mmol/l
0.5
1.1
0.83
109
699
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
141
2.67
7.01
1.4
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
201
1374
1.55
7.01
2.1
1.7
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
34
124
2.79
7.00
2.7
1.3
mmol/l
60.9
66.5
0.32
27
100
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
66
326
2.08
6.99
1.9
1.7
g/l
1.5
1.4
0.07
56
291
(3000330) Specific gravity of Urine by Test strip
80
424
1.95
6.97
3.3
2.9
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
121
731
1.72
6.92
3.2
2.6
g/l
10.4
10.7
0.29
116
659
(3048689) Calprotectin [Mass/mass] in Stool
198
1357
1.54
6.82
3.0
2.6
ug/g
126.6
112.8
0.29
157
1056
(3014007) Fractional oxyhemoglobin in Arterial blood
92
515
1.85
6.80
10.6
9.7
%
94.6
94.2
0.46
92
510
(3011397) Hemoglobin [Presence] in Urine by Test strip
313
2354
1.44
6.79
3.7
3.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
73
383
1.96
6.56
1.3
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
28
95
2.99
6.56
1.3
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
85
471
1.86
6.49
1.7
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
120
739
1.69
6.40
3.8
4.0
ug/l
7.6
16.4
0.42
98
587
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
47
211
2.27
6.33
1.6
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
36
143
2.56
6.31
3.2
2.1
%
16.4
16.8
0.25
28
69
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
182
2.35
6.13
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
182
2.35
6.13
1.3
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
228
1646
1.47
6.08
3.1
2.5
mmol/l
2.4
2.4
0.85
185
1444
(3020630) Protein [Mass/volume] in Serum or Plasma
104
627
1.72
6.01
2.1
2.4
g/l
65.8
67.1
0.84
99
574
(3000494) Fungus identified in Specimen by Culture
162
1098
1.54
5.85
1.6
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
825
7349
1.34
5.84
3.6
3.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
38
162
2.39
5.77
1.1
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
309
2383
1.39
5.69
1.8
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
77
433
1.83
5.64
1.8
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
89
523
1.75
5.64
5.2
3.3
mmol/l
2.1
1.7
0.49
62
382
(4035726)
112
702
1.65
5.61
1.3
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
19
56
3.43
5.59
1.1
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
184
1297
1.49
5.52
1.8
1.7
%
1.4
1.4
0.29
164
1160
(3051611) Lipemic interference index of Serum or Plasma
22
72
3.09
5.51
3.3
3.5
—
—
—
0
0
(3009343) pH of Capillary blood
91
543
1.73
5.47
5.3
3.3
ph
7.4
7.4
0.36
17
56
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
251
1891
1.41
5.27
2.3
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
40
184
2.21
5.13
1.6
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
93
571
1.68
5.05
1.7
1.7
g/l
1.1
1.5
1.40
87
522
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
212
2.11
5.04
1.3
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
11
23
4.82
5.02
1.5
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
883
8021
1.32
5.01
4.7
3.9
pmol/l
14.7
14.7
0.12
827
7323
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
35
154
2.31
4.99
7.1
5.1
iu/ml
1478.8
384.4
—
6
21
(3034274) Bile acid [Moles/volume] in Serum --fasting
44
213
2.10
4.98
2.3
2.2
umol/l
5.5
5.8
0.09
37
158
(3029937) Albumin [Presence] in Urine by Test strip
349
2800
1.34
4.92
5.1
3.6
estimate
0.0
0.0
1.28
154
925
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
100
632
1.63
4.87
5.3
3.0
ng/l
94.4
72.4
1.75
91
556
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
68
1143
0.57
4.86
3.3
4.1
%
31.4
32.3
0.31
50
780
(3045414) Leukocytes [Presence] in Urine
74
432
1.76
4.83
2.1
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
15
43
3.52
4.62
3.5
3.8
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
283
1.91
4.61
2.5
1.9
g/l
4.1
3.8
1.01
39
227
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
283
1.91
4.61
2.5
1.9
g/l
7.3
7.3
0.08
40
233
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
53
283
1.91
4.61
2.5
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
130
886
1.52
4.59
1.1
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
22
81
2.75
4.53
1.2
1.3
nmol/l
1.5
1.4
0.16
22
70
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
65
373
1.78
4.51
2.0
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
149
1050
1.47
4.47
1.4
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
764
6858
1.28
4.46
3.5
2.9
u/l
46.7
41.8
0.77
733
6420
(3021879) Hepatitis B virus core Ab [Presence] in Serum
124
842
1.52
4.45
1.6
1.5
—
—
—
0
0
(4281824)
20
71
2.85
4.40
1.2
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
291
2310
1.34
4.35
5.0
4.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1148
10934
1.47
4.33
18.8
10.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
10
22
4.57
4.30
1.0
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
42
212
2.01
4.30
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
61
349
1.79
4.29
2.0
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
38
185
2.09
4.28
2.8
2.2
g/l
126.1
132.6
1.02
30
132
(3014891) Appearance of Pleural fluid
8
9
8.94
4.28
2.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
40
199
2.04
4.26
1.3
1.2
u/ml
230.9
220.0
0.12
27
115
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
968
8982
1.31
4.26
6.3
5.1
mmol/mol
39.2
39.0
0.32
931
8370
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1144
10897
1.45
4.23
13.0
8.8
u/l
25.5
25.7
0.17
1124
10503
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
35
166
2.14
4.22
1.4
1.3
u/ml
105.3
97.2
0.28
13
28
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
271
1.88
4.18
2.6
2.0
g/l
3.1
3.0
0.31
40
230
(3049717) Cytology report of Urine Cyto stain
53
294
1.84
4.13
2.5
2.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
35
168
2.11
4.10
1.8
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
16
52
3.10
4.09
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
16
52
3.10
4.09
1.1
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
353
2903
1.30
4.06
3.8
3.2
mmol/l
7.7
7.9
0.30
310
2454
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
14
42
3.36
4.05
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
34
163
2.12
4.00
1.2
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
32
150
2.16
3.98
2.2
3.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
13
38
3.45
3.91
1.3
1.2
u/l
37.5
11.8
0.54
13
32
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
221
1710
1.35
3.89
1.4
1.3
iu/ml
47.8
30.0
0.67
61
540
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
76
1172
0.63
3.86
10.5
6.5
—
—
—
0
0
(1002224) Polysomnography panel
68
415
1.67
3.84
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
31
146
2.15
3.82
1.5
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
59
349
1.72
3.74
1.4
1.3
—
—
—
0
0
(3000492) Spirometry study
138
998
1.43
3.64
1.4
1.4
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
13
40
3.27
3.63
1.3
1.2
u/l
85.5
70.5
0.31
13
35
(3020682) Albumin/Creatinine [Ratio] in Urine
323
2664
1.28
3.58
5.5
4.0
mg/mmol
13.4
8.4
0.80
251
1701
(4024509)
19
74
2.59
3.56
1.7
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
1207
11675
1.55
3.55
30.0
16.7
pg
30.1
30.2
0.90
1199
11505
(3024731) MCV [Entitic volume]
1207
11675
1.55
3.55
30.0
16.7
fl
90.4
90.4
0.04
1199
11507
(3026361) Erythrocytes [#/volume] in Blood
1207
11677
1.55
3.52
30.1
16.8
e12/l
4.4
4.5
10.97
1179
11343
(3010813) Leukocytes [#/volume] in Blood
1207
11681
1.54
3.47
30.2
16.8
e9/l
7.1
6.7
3.88
1178
11344
(3007461) Platelets [#/volume] in Blood
1206
11670
1.54
3.46
30.2
16.8
e9/l
255.0
252.9
0.48
1181
11362
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
34
173
1.99
3.46
1.1
1.1
iu/ml
46.8
120.4
—
10
51
(3000963) Hemoglobin [Mass/volume] in Blood
1207
11683
1.54
3.44
30.3
16.9
g/l
131.9
135.9
16.78
1199
11512
(42529406) Shigella sp [Presence] in Stool by Culture
53
312
1.73
3.44
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
52
305
1.73
3.42
1.3
1.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
62
383
1.65
3.38
1.3
1.2
u/ml
0.2
0.5
—
5
27
(3014765) Yersinia sp identified in Stool by Organism specific culture
52
307
1.72
3.35
1.3
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
39
211
1.87
3.33
2.2
3.1
ratio
1.2
1.2
—
7
17
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
18
71
2.56
3.30
1.3
1.2
u/l
64.7
58.9
0.12
18
50
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
209
1643
1.32
3.30
1.3
1.2
u/ml
15.1
10.4
0.48
81
651
(3008295) Osmolality of Serum or Plasma
22
96
2.31
3.27
2.5
1.7
mosm/kgh2o
286.3
280.0
0.33
16
70
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
21
90
2.36
3.25
1.4
1.2
—
—
—
0
0
(4034850)
14
351
0.39
3.25
14.8
8.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
38
206
1.87
3.24
1.3
1.6
e6/l
4901.1
11742.6
1.35
25
157
(1001926) Buprenorphine [Presence] in Urine by Screen method
70
451
1.58
3.23
2.3
1.9
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
39
215
1.84
3.16
2.3
3.2
mg/l
46.9
46.8
0.00
34
180
(3011648) Oxygen content in Venous blood
15
55
2.75
3.16
1.9
4.8
%
11.2
10.4
0.25
15
55
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
215
1709
1.31
3.14
2.2
2.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
39
216
1.83
3.12
2.3
3.2
mg/l
36.1
34.1
0.08
34
183
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
46
268
1.74
3.12
4.4
3.3
u/ml
18.2
601.3
0.60
36
230
(40768797) Stomach Pathology biopsy report
166
1272
1.35
3.12
1.2
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
8
7.53
3.05
1.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1006
9509
1.27
3.05
5.7
4.6
mu/l
1.8
2.0
0.93
954
8771
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
36
196
1.86
3.04
1.2
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
38
211
1.83
3.02
1.7
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
65
419
1.58
3.01
12.1
10.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
31
161
1.95
3.01
4.5
2.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
99
699
1.45
3.00
4.2
2.7
mmol/l
1.2
1.2
0.21
91
584
(40761536) Microorganisms panel - Urine sediment
125
922
1.39
2.98
4.8
3.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
80
542
1.51
2.98
1.4
1.4
iu/l
18.5
22.5
0.56
68
449
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
40
3.02
2.97
6.2
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
40
3.02
2.97
6.2
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
68
446
1.55
2.93
2.1
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
123
908
1.39
2.92
4.1
2.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
42
244
1.75
2.89
1.2
1.4
—
—
—
0
0
(4198724)
14
52
2.71
2.89
2.9
1.9
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
14
52
2.71
2.89
4.4
4.0
u/ml
27.4
81.3
0.87
14
52
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
110
798
1.41
2.89
1.3
1.2
iu/ml
105.5
149.8
1.00
40
310
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
49
298
1.67
2.87
1.3
1.3
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
6
9
6.69
2.87
4.8
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
84
581
1.48
2.84
2.2
1.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
58
370
1.59
2.82
1.4
1.4
u/l
9.1
9.1
0.01
49
301
(3028300) Cannabinoids [Presence] in Urine
84
582
1.47
2.82
2.2
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
27
137
1.99
2.81
1.1
1.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
59
2.56
2.79
2.0
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
83
576
1.47
2.76
2.2
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
41
241
1.72
2.73
1.6
1.5
ug/g
226.3
307.2
1.89
28
134
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
30
160
1.90
2.72
1.1
1.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
11
37
2.99
2.69
2.6
4.2
umol/l
108.5
163.7
—
6
22
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
168
1.87
2.69
1.1
1.2
u/ml
2.1
4.2
—
8
54
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
27
140
1.95
2.66
3.6
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
60
392
1.56
2.66
2.5
2.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
37
213
1.76
2.65
2.7
2.3
ug/min
82.2
123.3
0.35
26
128
(3012441) Differential panel - Pleural fluid
16
67
2.41
2.63
1.3
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
29
155
1.89
2.62
1.5
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
18
80
2.27
2.61
1.3
1.3
e6/l
1913.2
1834.8
0.03
11
53
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
39
230
1.72
2.58
1.7
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
37
215
1.74
2.58
2.5
1.9
—
—
—
0
0
(4306422)
28
150
1.89
2.53
1.1
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
91
656
1.42
2.50
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
81
572
1.44
2.49
2.3
1.9
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
30
167
1.82
2.42
1.2
1.2
u/ml
6.2
3.8
0.32
17
72
(4268621)
23
117
1.98
2.41
2.0
2.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
28
153
1.85
2.39
1.1
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
22
3.65
2.36
1.3
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
76
537
1.44
2.35
2.3
2.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
49
316
1.57
2.33
3.2
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
41
253
1.64
2.32
3.3
2.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
22
112
1.98
2.31
1.2
1.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
18
3.90
2.25
2.1
1.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
9
5.57
2.21
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
87
638
1.39
2.20
1.2
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
48
2.51
2.19
2.1
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
38
234
1.64
2.19
1.3
1.4
ug/l
3.6
3.4
0.08
33
220
(40768443) Skin Pathology biopsy report
57
387
1.49
2.17
1.5
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
14
4.30
2.15
1.7
1.4
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
6
14
4.30
2.15
2.0
3.8
%
64.5
75.3
—
6
8
(3033799) Differential panel - Peritoneal fluid
6
14
4.30
2.15
1.5
1.6
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
14
61
2.31
2.15
2.1
2.2
—
1.8
—
0
6
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
14
61
2.31
2.15
1.6
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
45
291
1.57
2.13
1.2
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
84
617
1.39
2.11
3.6
3.4
pmol/l
4.5
4.6
0.25
79
553
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
36
221
1.65
2.10
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
37
2.72
2.10
2.4
2.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
43
2.57
2.10
1.8
1.9
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
165
1343
1.26
2.03
1.6
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
59
410
1.46
2.02
5.8
3.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
26
3.09
2.01
1.0
1.4
ug/l
8.8
7.9
—
8
26
(3021387) Prolactin [Units/volume] in Serum or Plasma
74
537
1.40
2.01
1.7
1.6
mu/l
345.6
295.4
0.65
64
483
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
18
91
1.99
1.95
1.1
1.4
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
5
11
4.56
1.94
1.2
1.2
u/ml
3.3
0.0
—
5
5
(3034426) Prothrombin time (PT)
9
33
2.74
1.93
1.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
15
71
2.13
1.92
1.3
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
18
92
1.97
1.90
1.2
2.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
21
114
1.86
1.88
1.1
1.1
%
95.8
95.2
0.03
21
106
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
122
1.82
1.85
1.3
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
40
2.51
1.84
1.1
1.2
nmol/l
107.6
139.4
—
10
40
(3051101) Glucose [Moles/volume] in Cord blood
5
12
4.18
1.82
3.2
6.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
298
2606
1.19
1.82
1.8
1.6
mmol/l
1.3
1.4
0.33
263
2188
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
29
2.77
1.79
2.4
4.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
20
109
1.85
1.78
1.2
1.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
67
2.10
1.76
1.4
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
88
1.94
1.75
2.1
2.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
17
88
1.94
1.75
1.1
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
28
170
1.66
1.74
1.1
1.1
u/ml
1.6
2.5
—
9
71
(3009542) Hematocrit [Volume Fraction] of Blood
1020
9818
1.19
1.74
22.0
12.1
%
39.0
40.1
4.58
831
7401
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
24
2.93
1.72
1.7
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
88
676
1.32
1.71
2.2
2.3
ug/l
16.5
6.3
0.85
71
600
(3019225) pH of Specimen
64
859
0.73
1.67
3.2
3.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
42
286
1.48
1.63
1.8
1.9
iu/l
2.7
5.0
2.41
17
103
(3019309) Folate [Moles/volume] in Red Blood Cells
189
1601
1.21
1.63
1.8
1.7
nmol/l
1104.4
1194.1
0.78
143
1209
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
21
120
1.76
1.62
1.1
1.3
nmol/l
—
0.5
—
0
13
(3002619) Bacteria identified in Specimen by Culture
6
20
3.01
1.58
1.2
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
8
33
2.43
1.54
1.1
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
141
1167
1.23
1.53
2.6
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
58
778
0.73
1.52
3.9
3.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
15
3.34
1.52
4.8
2.6
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
9
37
2.44
1.48
1.1
1.7
pmol/l
12.3
14.5
—
9
30
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
45
318
1.43
1.48
1.7
1.6
iu/ml
0.0
0.3
—
9
55
(3012516) Albumin [Mass/volume] in Urine
286
2535
1.16
1.47
3.9
3.2
mg/l
70.2
260.4
1.98
214
1627
(3003740) Influenza virus B Ag [Presence] in Specimen
31
203
1.54
1.46
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
31
203
1.54
1.46
1.1
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
28
2.51
1.45
1.4
1.8
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
52
2.13
1.44
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
26
164
1.60
1.44
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
16
3.13
1.44
1.4
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
59
2.04
1.43
1.2
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
13
66
1.98
1.43
1.5
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
6
22
2.74
1.43
3.3
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
22
133
1.67
1.43
1.2
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
15
81
1.86
1.40
1.1
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
9
40
2.26
1.40
1.8
2.1
umol/l
27.2
29.3
—
9
40
(1761868) Lipid panel - Serum or Plasma
413
3775
1.14
1.38
2.6
2.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
29
190
1.54
1.38
3.2
1.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
9
41
2.20
1.37
1.3
1.2
u/l
12.7
10.9
—
9
36
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
61
462
1.34
1.35
2.2
1.7
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
20
120
1.68
1.34
2.4
3.3
u/ml
41.3
73.6
0.45
20
111
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
11
54
2.05
1.33
1.3
1.5
—
217.5
—
0
8
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
113
933
1.23
1.29
2.5
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
70
546
1.30
1.28
1.4
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
20
122
1.65
1.27
1.7
1.5
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
20
122
1.65
1.27
1.5
1.3
—
58.4
—
0
8
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
15
84
1.79
1.27
1.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
178
1.53
1.27
1.3
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
49
363
1.36
1.26
1.4
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
26
171
1.53
1.24
4.2
2.8
mmol/l
2.4
2.6
0.16
11
112
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
24
155
1.56
1.23
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
45
2.01
1.23
2.7
3.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
84
675
1.26
1.22
3.1
2.7
e9/l
3.9
4.1
0.55
78
544
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
182
1581
1.18
1.22
3.0
2.9
ug/l
0.6
0.7
1.86
125
1002
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
79
631
1.27
1.21
3.0
2.6
ng/l
271.4
185.8
0.39
70
569
(3017817) Protein [Mass] in Urine collected for unspecified duration
13
71
1.84
1.19
2.2
2.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
29
417
0.69
1.19
1.4
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
20
2.51
1.15
1.8
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
114
0.44
1.12
1.0
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
11
58
1.90
1.12
1.1
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
40
2.01
1.12
1.1
1.2
—
—
—
0
0
(3010421) pH of Blood
31
217
1.44
1.12
3.9
2.7
ph
7.4
7.4
0.19
24
167
(3028308) Erythrocytes [#/volume] in Pleural fluid
13
73
1.79
1.11
1.3
1.3
e6/l
20949.3
106385.7
—
8
38
(3035320) C reactive protein [Mass/volume] in Body fluid
13
73
1.79
1.11
4.2
2.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
31
2.26
1.10
1.7
1.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
16
96
1.68
1.10
1.2
1.8
—
—
—
0
0
(44806420)
5
21
2.39
1.09
1.6
2.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
81
1.74
1.09
1.4
1.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
32
2.19
1.08
1.6
1.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
32
2.19
1.08
2.4
2.0
ug/l
134.7
86.2
—
7
32
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
7
32
2.19
1.08
1.6
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
253
2276
1.14
1.07
4.4
3.7
kg/l
1.0
1.0
0.46
29
307
(3004588) Protein electrophoresis panel - Serum or Plasma
66
526
1.27
1.06
2.3
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
162
1.49
1.04
1.2
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
9
46
1.96
1.03
1.1
1.1
iu/ml
158.6
184.6
—
9
46
(4133840)
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
34
2.06
1.03
1.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
63
502
1.27
1.02
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
63
502
1.27
1.02
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
63
502
1.27
1.02
1.4
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
22
148
1.49
0.98
1.2
1.2
u/l
35.1
30.8
0.07
22
128
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
36
1.95
0.97
1.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
36
1.95
0.97
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
36
1.95
0.97
1.3
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
36
1.95
0.97
1.3
1.8
—
—
—
0
0
(4027681)
12
69
1.75
0.96
1.1
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
77
1.70
0.95
6.0
3.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
23
158
1.46
0.94
1.4
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
88
1045
0.83
0.93
1.5
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
33
441
0.74
0.92
1.8
1.9
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
62
500
1.25
0.92
1.4
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.3
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
28
2.15
0.91
1.3
1.9
—
—
—
0
0
(4094501)
33
244
1.36
0.91
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
18
118
1.53
0.91
1.1
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
94
1.60
0.90
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
29
2.07
0.89
1.5
1.8
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
13
79
1.65
0.88
1.1
1.1
mg/l
235.2
212.6
0.34
13
68
(3032773) Endomysium IgG Ab [Titer] in Serum
16
103
1.56
0.87
1.3
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
103
1.56
0.87
1.5
1.5
mmol/l
10.5
11.5
—
6
18
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
43
1.87
0.87
1.1
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
31
1.94
0.84
1.3
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
30
222
1.36
0.84
1.2
1.6
mg/l
660.5
459.5
0.30
30
211
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
77
644
1.21
0.84
1.1
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
105
1.53
0.82
1.1
1.3
nmol/l
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
13
81
1.61
0.81
1.1
1.2
mg/l
33.3
31.2
0.15
13
62
(3025941) Bacteria identified in Stool by Culture
69
574
1.21
0.80
1.3
1.2
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
24
0.00
0.79
0.0
1.1
—
0.7
—
0
17
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
24
0.00
0.79
0.0
1.2
—
28.8
—
0
16
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
131
1.46
0.78
2.2
2.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
13
83
1.57
0.75
1.4
1.4
%
5.9
29.5
—
7
54
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
13
83
1.57
0.75
1.9
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
75
1.61
0.75
1.0
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
24
2.09
0.74
1.0
1.0
mg/g
5.3
7.0
—
5
24
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3035880) pH of Pleural fluid
7
38
1.85
0.73
1.3
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
15
100
1.51
0.73
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
56
1.61
0.72
1.4
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
25
185
1.36
0.72
1.1
1.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
13
84
1.55
0.72
1.2
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
23
168
1.38
0.71
2.1
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
58
1.56
0.70
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
13
85
1.53
0.69
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
13
85
1.53
0.69
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
13
85
1.53
0.69
1.2
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
27
1.86
0.68
1.0
1.1
—
421.4
—
0
8
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
59
1.53
0.68
4.2
2.6
—
—
—
0
0
(4062490)
14
94
1.49
0.67
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1030
10105
1.10
0.66
4.7
4.4
mmol/l
2.7
2.8
4.83
985
9369
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
287
2678
1.09
0.65
4.3
4.7
ug/l
2.2
2.2
0.01
268
2403
(40768800) Prostate Pathology biopsy report
10
154
0.65
0.64
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
209
1923
1.10
0.64
1.6
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
38
308
1.24
0.60
1.7
1.7
nmol/l
43.9
39.0
0.59
38
299
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
151
0.66
0.60
1.0
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
72
1.53
0.59
1.2
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
64
1.57
0.58
1.5
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
175
1.32
0.58
1.8
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
13
89
1.47
0.58
1.2
1.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1013
9950
1.09
0.57
4.3
4.0
mmol/l
4.5
4.7
7.72
969
9289
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
35
1.72
0.57
1.0
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
81
1.49
0.57
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
62
719
0.86
0.56
1.4
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
81
711
1.15
0.55
2.3
2.1
nmol/l
12.2
13.0
0.29
74
626
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
6
37
1.62
0.55
1.8
2.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
61
1.48
0.53
1.1
1.5
umol/l
10.5
11.3
—
9
56
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
108
1.39
0.53
1.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
97
0.62
0.52
1.2
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
52
444
1.18
0.51
1.7
1.6
mg/l
7.1
4.1
0.55
37
318
(3029396) Erythrocyte agglutination [Presence] in Blood
6
41
1.47
0.50
3.5
3.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
965
9482
1.07
0.49
3.8
3.6
mmol/l
1.3
1.3
0.45
912
8763
(3000012) Reticulocyte production index
7
46
1.52
0.48
1.3
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
254
1.23
0.47
2.4
2.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1003
9877
1.07
0.45
4.2
4.0
mmol/l
1.4
1.5
2.25
957
9161
(3014148) Varicella zoster virus Ab [Titer] in Serum
19
147
1.30
0.45
1.3
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
15
112
1.34
0.44
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
69
1.45
0.44
1.3
2.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
51
442
1.16
0.44
1.5
1.4
miu/ml
180.1
243.5
0.80
24
232
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
157
1.28
0.43
1.0
1.5
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
8
56
1.43
0.42
3.3
3.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
14
184
0.76
0.42
1.7
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
33
1.52
0.41
2.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
208
1959
1.07
0.40
1.7
1.7
pmol/l
34463718.0
37561105.6
0.03
177
1648
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
34
1.47
0.40
1.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
47
409
1.15
0.39
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
110
1196
0.91
0.39
1.2
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
9
68
1.33
0.37
1.1
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
69
1.31
0.37
2.8
1.9
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
5
37
1.35
0.37
1.0
2.2
ug/l
16.4
242.6
—
5
32
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
45
395
1.14
0.35
1.5
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
27
227
1.19
0.34
1.1
1.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
44
1.37
0.34
1.5
1.2
%
101.2
108.8
—
6
35
(3034891) Synovial lining cells/100 cells in Synovial fluid
6
45
1.33
0.33
1.5
1.4
%
—
4.9
—
0
12
(3022621) pH of Urine by Test strip
71
644
1.11
0.33
2.6
2.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
136
1.25
0.33
1.5
1.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
183
1.21
0.32
5.3
3.9
%
61.6
57.2
1.13
22
183
(40768793) Breast Pathology biopsy report
27
230
1.18
0.31
1.1
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
45
400
1.13
0.30
1.4
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
212
1.18
0.30
1.2
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
93
1.29
0.30
2.3
4.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
70
642
1.10
0.28
1.7
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
57
626
0.91
0.27
1.4
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
177
1.19
0.27
5.3
3.6
e9/l
4.3
4.1
0.18
21
177
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
116
0.77
0.27
1.0
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
168
1.19
0.27
1.2
1.1
u/ml
39.2
7.3
—
9
71
(3037121) Protein [Mass/volume] in Urine
37
328
1.13
0.27
2.4
3.7
g/l
0.2
0.3
0.50
19
146
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
25
215
1.17
0.26
1.8
1.9
pmol/l
190.1
215.8
0.69
25
204
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
66
1.21
0.26
1.3
1.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
8
66
1.21
0.26
1.0
1.1
—
56.6
—
0
5
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
86
1.28
0.26
1.0
1.4
u/ml
1.6
0.1
—
5
35
(44813793)
10
77
1.30
0.26
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
74
0.67
0.26
1.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
9
73
1.23
0.25
1.6
1.5
g/l
0.8
1.0
—
9
73
(1617658) Protocol used for examination of sentinel lymph nodes
9
74
1.22
0.25
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
76
1.19
0.24
1.2
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
77
1.17
0.24
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
981
9714
1.04
0.24
4.4
4.1
mmol/l
5.8
5.8
0.02
930
8884
(3005033) Fetal Nuchal fold Thickness US
44
398
1.11
0.24
1.4
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
161
1.18
0.24
1.3
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
81
0.74
0.24
3.0
1.8
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
79
1.27
0.22
1.2
1.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
13.1
—
0.4
—
0
11
(3007542) Rye IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
182
1.16
0.21
1.1
1.1
u/ml
20.8
5.2
—
9
74
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(44806071)
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
14
0.00
0.20
0.0
6.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.8
—
62.1
—
0
14
(3023419) Bacteria identified in Sputum by Culture
12
100
1.20
0.18
2.1
3.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
13
111
1.17
0.15
1.4
1.6
%
76.3
61.4
—
8
76
(40768795) Lymph node Pathology biopsy report
8
73
1.10
0.15
1.0
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
44
410
1.08
0.15
1.5
1.5
—
—
—
0
0
(4146454)
7
88
0.79
0.14
1.4
2.8
—
—
—
0
0
(44790047)
9
106
0.85
0.13
1.6
1.5
—
—
—
0
0
(44806118)
9
106
0.85
0.13
1.6
1.5
—
—
—
0
0
(44790048)
9
106
0.85
0.13
1.6
1.5
—
—
—
0
0
(44790049)
9
106
0.85
0.13
1.6
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
114
1.14
0.12
1.2
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
214
2184
0.98
0.11
3.9
4.2
%
25.1
21.4
1.55
77
1022
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
46
1.09
0.09
1.0
1.2
—
79.7
—
0
7
(3010726) Horse dander IgE Ab [Units/volume] in Serum
24
223
1.08
0.09
1.1
1.1
u/ml
4.9
4.0
—
8
59
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
97
1.14
0.09
1.6
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
257
0.93
0.08
1.0
1.1
u/ml
1.0
2.9
1.20
12
111
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
107
1.12
0.08
1.0
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
58
1.03
0.08
1.2
1.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
65
0.77
0.08
2.2
1.6
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
7
67
1.05
0.08
1.1
1.0
mg/l
281.9
277.8
—
7
60
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
85
1.06
0.07
1.3
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
92
0.87
0.06
2.4
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
93
0.86
0.06
2.5
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
25
236
1.06
0.06
1.0
1.1
u/ml
11.8
4.8
0.46
15
130
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
99
1.11
0.06
1.6
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
99
1.11
0.06
1.6
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
99
1.11
0.06
1.6
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
99
1.11
0.06
1.6
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
103
0.87
0.06
2.6
2.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
20
213
0.94
0.06
3.2
3.2
mg/l
25.4
27.0
0.06
11
126
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
17
158
1.08
0.06
1.0
1.1
u/ml
0.0
0.7
—
5
43
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
33
344
0.96
0.05
2.3
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
100
1.10
0.05
1.6
1.3
—
—
—
0
0
(3020891) Body temperature
33
343
0.96
0.05
5.1
4.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
23
219
1.05
0.04
1.6
1.2
—
28.3
—
0
20
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
72
733
0.98
0.03
3.5
2.2
ml/min/173m2
66.4
72.9
0.67
39
280
(4010399)
66
650
1.02
0.02
1.7
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
134
1329
1.01
0.02
1.9
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
302
1.03
0.02
1.1
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
27
263
1.03
0.01
1.4
1.2
u/ml
44.0
10.8
—
5
35
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
12
116
1.03
0.00
1.3
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
20
198
1.01
0.00
1.5
1.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
228
1.01
0.00
1.0
1.1
u/ml
1.0
1.7
0.31
11
105
(3019060) Gas panel - Arterial blood
52
522
1.00
0.00
3.9
4.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
32
321
1.00
0.00
2.2
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
11
107
1.03
0.00
1.4
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
195
0.97
0.00
1.5
1.7
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
8
80
1.00
0.00
1.1
1.3
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
9.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
34.5
—
0
5
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
21.7
—
0
5
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
1.1
—
0
5
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
86
0.93
0.00
1.3
2.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.0
—
8.0
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
49
1.02
0.00
7.8
7.8
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
73
0.96
0.00
19.6
14.5
nmol/l
825.9
810.1
—
7
68
(3051339) Copper [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.0
—
16.8
—
0
9
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
6
0.00
0.00
0.0
2.3
—
141.5
—
0
6
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
72
0.97
0.00
1.3
1.6
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
6
67
0.90
0.00
12.8
10.5
mmol/l
0.7
0.6
—
6
62
(3017315) Amylase [Enzymatic activity/volume] in Urine
5
56
0.89
0.00
1.0
1.2
u/l
136.1
480.2
—
5
51
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
79
0.89
0.00
2.1
1.3
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
5.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
1.8
—
1.8
—
0
6
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
178.8
—
0
6
(3041806) Other cells [#/volume] in Blood by Manual count
7
76
0.92
0.00
1.7
1.5
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
72
0.97
0.00
1.3
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
78
0.90
0.00
2.1
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
72
0.97
0.00
1.3
1.6
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_OTHER_SURGI_FOLLOW__CARE – Other surgical follow-up care
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).